EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

“Pleiotropic” Effects of Antibiotics: New Modulators in Human Diseases

Carlo Airola iD, Andrea Severino iD, Irene Spinelli, Antonio Gasbarrini iD, Giovanni Cammarota, Gianluca Ianiro iD, Francesca Romana Ponziani iD

Antibiotics · 04.12.2024 · 13 (12) · 1176

DOI: 10.3390/antibiotics13121176 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antibiotics, online erschienen am 04.12.2024. Verfasst von Carlo Airola und 6 weiteren Autor:innen. Beteiligte Einrichtung: Digestive Disease Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 206 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antibiotics, widely used medications that have significantly increased life expectancy, possess a broad range of effects beyond their primary antibacterial activity. While some are recognized as adverse events, others have demonstrated unexpected benefits. These adjunctive effects, which have been defined as “pleiotropic” in the case of other pharmacological classes, include immunomodulatory properties and the modulation of the microbiota. Specifically, macrolides, tetracyclines, and fluoroquinolones have been shown to modulate the immune system in both acute and chronic conditions, including autoimmune disorders (e.g., rheumatoid arthritis, spondyloarthritis) and chronic inflammatory pulmonary diseases (e.g., asthma, chronic obstructive pulmonary disease). Azithromycin, in particular, is recommended for the long-term treatment of chronic inflammatory pulmonary diseases due to its well-established immunomodulatory effects. Furthermore, antibiotics influence the human microbiota. Rifaximin, for example, exerts a eubiotic effect that enhances the balance between the gut microbiota and the host immune cells and epithelial cells. These pleiotropic effects offer new therapeutic opportunities by interacting with human cells, signaling molecules, and bacteria involved in non-infectious diseases like spondyloarthritis and inflammatory bowel diseases. The aim of this review is to explore the pleiotropic potential of antibiotics, from molecular and cellular evidence to their clinical application, in order to optimize their use. Understanding these effects is essential to ensure careful use, particularly in consideration of the threat of antimicrobial resistance.

Schlagwörter

Stichwörter der Autor:innen

eubioticsimmune systemimmunomodulatorsmicrobiota

Autor:innen und Institutionen

  • Digestive Disease Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy.
  • Dipartimento Universitario di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Largo Francesco Vito 1, 00168 Rome, Italy.

ORCID-Profile: Carlo Airola, Andrea Severino, Antonio Gasbarrini, Gianluca Ianiro, Francesca Romana Ponziani

Zitieren

APA

Airola, C., Severino, A., Spinelli, I., Gasbarrini, A., Cammarota, G., Ianiro, G., & Ponziani, F. R. (2024). “Pleiotropic” Effects of Antibiotics: New Modulators in Human Diseases. Antibiotics, 13(12), 1176. https://doi.org/10.3390/antibiotics13121176

Vancouver

Airola C, Severino A, Spinelli I, Gasbarrini A, Cammarota G, Ianiro G, et al. “Pleiotropic” Effects of Antibiotics: New Modulators in Human Diseases. Antibiotics. 2024;13(12):1176. doi:10.3390/antibiotics13121176

BibTeX
@article{Airola2024,
  author = {Airola, Carlo and Severino, Andrea and Spinelli, Irene and Gasbarrini, Antonio and Cammarota, Giovanni and Ianiro, Gianluca and Ponziani, Francesca Romana},
  title = {“Pleiotropic” Effects of Antibiotics: New Modulators in Human Diseases},
  journal = {Antibiotics},
  year = {2024},
  volume = {13},
  number = {12},
  pages = {1176},
  doi = {10.3390/antibiotics13121176}
}
Kostenlos starten →